Literature DB >> 12966217

Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor.

Elizabeth M Powell1, Sven Mühlfriedel, Jürgen Bolz, Pat Levitt.   

Abstract

The initial axonal projections between the cerebral cortex and thalamus are established during embryogenesis. Chemoattractants and repellents are thought to provide specific guidance cues for directional growth of these pathways. Hepatocyte growth factor/scatter factor (HGF/SF) serves as an attractant for developing motor neurons, and its distribution in embryonic pallidum, pallium and thalamus suggests a similar role in forebrain development. We examined the effectiveness of HGF/SF in regulating thalamic and cortical neuronal growth using in vitro assays. HGF/SF increased neurite outgrowth of thalamic, but not cortical neurons, grown in dissociated cultures or as explants. HGF/SF also exhibited a chemoattractant property for thalamic axons, promoting the extension of neurites towards an HGF/SF source. These experiments demonstrate HGF/SF has the capacity to selectively direct thalamocortical projections into an intermediate target, the pallidum, and eventually to their final cortical destination. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966217     DOI: 10.1159/000072268

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  17 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

2.  Trekking through the telencephalon: hepatocyte growth factor-mediated guidance for parvalbumin-expressing interneurons.

Authors:  Janice R Naegele
Journal:  Epilepsy Curr       Date:  2010-07       Impact factor: 7.500

3.  Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain.

Authors:  Matthew C Judson; Kathie L Eagleson; Lily Wang; Pat Levitt
Journal:  J Comp Neurol       Date:  2010-11-01       Impact factor: 3.215

Review 4.  [Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?].

Authors:  T Nickl-Jockschat; T M Michel
Journal:  Nervenarzt       Date:  2011-05       Impact factor: 1.214

5.  The autism risk genes MET and PLAUR differentially impact cortical development.

Authors:  Kathie L Eagleson; Daniel B Campbell; Barbara L Thompson; Mica Y Bergman; Pat Levitt
Journal:  Autism Res       Date:  2010-12-03       Impact factor: 5.216

6.  Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation.

Authors:  Guillermina López-Bendito; Aline Cautinat; Juan Antonio Sánchez; Franck Bielle; Nuria Flames; Alistair N Garratt; David A Talmage; Lorna W Role; Patrick Charnay; Oscar Marín; Sonia Garel
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

7.  Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons.

Authors:  Gregory B Bissonette; Mihyun H Bae; Tejas Suresh; David E Jaffe; Elizabeth M Powell
Journal:  Behav Brain Res       Date:  2013-11-07       Impact factor: 3.332

Review 8.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

9.  Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain.

Authors:  Matthew C Judson; Mica Y Bergman; Daniel B Campbell; Kathie L Eagleson; Pat Levitt
Journal:  J Comp Neurol       Date:  2009-04-10       Impact factor: 3.215

10.  Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway.

Authors:  Chol Seung Lim; Randall S Walikonis
Journal:  Cell Signal       Date:  2007-12-27       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.